• Home
  • NEW DAY MEDICINE
  • 7(45)2022
  • 35 — 7 (45) 2022 — Mullabayeva G.U., Maksudova L.O., FEATURES OF THE COURSE OF ARTERIAL HYPERTENSION AGAINST THE BACKGROUND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

35 — 7 (45) 2022 — Mullabayeva G.U., Maksudova L.O., FEATURES OF THE COURSE OF ARTERIAL HYPERTENSION AGAINST THE BACKGROUND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

FEATURES OF THE COURSE OF ARTERIAL HYPERTENSION AGAINST THE BACKGROUND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Mullabayeva G.U., Republican Specialized Scientific and Practical Center of Cardiology

Maksudova L.O., Bukhara Cardiodispensary

Resume

The article provides an overview of the existing groups of drugs for the treatment of hypertension in patients with COPD. The authors conducted a critical analysis of the results of numerous studies. The article is intended both for primary care physicians and cardiologists of polyclinics and specialized institutions

Key words: arterial hypertension, COPD, antihypertensive therapy

First page

171

Last page

178

For citation: Mullabayeva G.U., Maksudova L.O., FEATURES OF THE COURSE OF ARTERIAL HYPERTENSION AGAINST THE BACKGROUND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE //New Day in Medicine 7(45)2022 171-178 https://l.clck.bar/138cf

LIST OF REFERENCES:

  1. Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults – United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(46):938–943.
  2. Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease surveillance-United States, 1971–2000. MMWR Survell Summ 2002;51(6):1–16.
  3. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20): 2043–2050.
  4. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25: 305–313.
  5. Wells K.B., Stewart A., Hays R.D., et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262(7):914–919.
  6. Chobanian A.V., Bakris G.L., Black H.R., et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252.
  7. Appel L.J. The verdict from ALLHAT – thiazide diuretics are the preferred initial therapy for hypertension. JAMA. 2002;288(23):3039–3042.
  8. Herrin M.A., Feemster L.C., Crothers K., Uman J.E., Bryson C.L., Au D.H. Combination antihypertensive therapy among patients with COPD. Chest. 2013;143(5):1312–1320.
  9. Wong C.S., Pavord I.D., Williams J., Britton J.R., Tattersfield A.E. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 1990;336(8728): 1396–1399.
  10. Bear R., Goldstein M., Phillipson E., et al. Effect of metabolic alkalosis on respiratory function in patients with chronic obstructive lung disease. Can Med Assoc J. 1977;117(8):900–903.

file

download